•
Sep 30, 2021

Stoke Therapeutics Q3 2021 Earnings Report

EPS
-$0.61
Previous year: -$0.41
+48.8%
Cash and Equivalents
$149M
Free Cash Flow
-$15M
Total Assets
$254M

Stoke Therapeutics

Stoke Therapeutics